Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03824093 · ClinicalTrials.gov registry record · NA
High and Low Resource Interventions to Promote HPV Vaccines
A NA study of Human Papilloma Virus and Communication, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 1
- Study location
NCT03824093: Completed NA study of Human Papilloma Virus and Communication, sponsored by Children's Mercy Hospital Kansas City.
NCT03824093 is a NA study of Human Papilloma Virus and Communication that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 225 participants, below the 8,436-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03824093, a NA study of Human Papilloma Virus and Communication, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
Human Papillomavirus (HPV) is a significant public health issue affecting nearly 14 million people in the United States. HPV can lead to cervical, oropharyngeal, anal, and penile cancers as well as genital warts.The purpose of this study is to test the comparative effectiveness of two interventions, AFIX only vs. AFIX + communication training, to increase Human Papillomavirus (HPV) vaccination rates among adolescent patients in outpatient clinic settings. Providers and staff at four pediatric practices will be randomized to receive an in-person AFIX consultation or an AFIX consultation combined with communication training and commitment poster displays. Provider and parent data will be collected via a tablet computer RedCap survey. Additional practice and provider level HPV vaccination rates will be collected via patient de-identified claims data. The results of this study could contribute to the existing body of literature that suggests provider recommendations and routine vaccination assessments are key to increasing HPV vaccination uptake. This project has the potential to lead to the implementation and dissemination of low resource interventions to increase HPV vaccination rates among children and adolescents.
Primary Outcome
Practice and provider level HPV vaccination rates will be collected from patient de-identified claims data.
Conditions Studied
Interventions
- BEHAVIORAL AFIX Only
- BEHAVIORAL AFIX+ Provider Communication Training
Study Locations (1)
Missouri
- Children's Mercy Hospital Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-05-06 |
| Phase | NA |
What the finished NCT03824093 record still lists
NCT03824093 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 8,436-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (97% lower).
The record links to 5 conditions, with Human Papilloma Virus appearing as the primary indexed condition, and to 2 interventions - of which AFIX Only is the first listed.
NCT03824093 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03824093 about?
NCT03824093 is a clinical study titled "High and Low Resource Interventions to Promote HPV Vaccines". Human Papillomavirus (HPV) is a significant public health issue affecting nearly 14 million people in the United States. HPV can lead to cervical, oropharyngeal, anal, and penile cancers as well as genital warts.The purpose of this study is to test the comparative effectiveness of two interventions,...
What is the current status of trial NCT03824093?
This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2018-07-01. Estimated completion is 2020-05-06.
What conditions does trial NCT03824093 study?
This clinical trial studies the following conditions: Human Papilloma Virus, Communication, Satisfaction, Meningitis, Meningococcal, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination.
What interventions are being tested in trial NCT03824093?
The interventions under investigation include: AFIX Only (BEHAVIORAL), AFIX+ Provider Communication Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03824093?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03824093 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03824093's enrollment target sits among peer trials
225 18th of 39 higher than 22 of 39 other Human Papilloma Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Papilloma Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
RECRUITING · NA
-
Provider Recommendation and HPV Vaccination
RECRUITING · NA
-
Impact of Standing Orders Optimization
ACTIVE NOT RECRUITING · NA
-
Development of a Self-collection Device for Cervical Cancer Screening
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI